Liederbach, Germany

Lars Bierer

This inventor holds 1 USPTO granted patent. Top assignee: Clariant Corporation. Active years: 2005.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lars Bierer: Innovator in Chemical Processes

Introduction

Lars Bierer is a notable inventor based in Liederbach, Germany. He has made significant contributions to the field of chemistry, particularly in the preparation of substituted benzoyl chlorides. His innovative approach has led to the development of a patented process that enhances chemical synthesis.

Latest Patents

Lars Bierer holds a patent for a process for preparing substituted benzoyl chlorides. This invention involves reacting a benzaldehyde with a chlorinating agent in the presence of a free-radical initiator and a solvent at temperatures ranging from -20 to +200 °C. The process allows for the creation of various substituted benzoyl chlorides, which have important applications in the chemical industry.

Career Highlights

Bierer is currently employed at Clariant Corporation, a leading global company in specialty chemicals. His work at Clariant has allowed him to focus on innovative chemical processes that contribute to the company's success. With a patent portfolio that includes 1 patent, he continues to push the boundaries of chemical innovation.

Collaborations

Throughout his career, Lars Bierer has collaborated with esteemed colleagues such as Thomas Wessel and Joachim Ritzer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in chemical research.

Conclusion

Lars Bierer is a prominent figure in the field of chemical innovation, with a focus on the preparation of substituted benzoyl chlorides. His contributions through patents and collaborations highlight his commitment to advancing chemical processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…